Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

NextCell Pharma AB

Closing information (x1000 SEK)

Closing information 2023/08 2022/08 2021/08
Turnover 10,113 Less Arrow 5,589 Less Arrow 3,912
Financial expenses 3 More Arrow 14 Less Arrow 8
Earnings before taxes -39,812 More Arrow -34,554 More Arrow 0
EBITDA -40,554 More Arrow -34,567 More Arrow 437
Total assets 88,827 More Arrow 124,655 More Arrow 155,626
Current assets 67,273 More Arrow 106,755 More Arrow 146,480
Current liabilities 10,080 Less Arrow 6,932 Less Arrow 3,957
Equity capital 75,727 More Arrow 115,539 More Arrow 150,093
- share capital 7,048 Equal arrow 7,048 Equal arrow 7,048
Employees (average) 17 Less Arrow 15 Less Arrow 13

Financial ratios

Fiscal year 2023/08 2022/08 2021/08
Solvency 85.3% More Arrow 92.7% More Arrow 96.4%
Turnover per employee 595 Less Arrow 373 Less Arrow 301
Profit as a percentage of turnover -393.7% Less Arrow -618.3% More Arrow 0%
Return on assets (ROA) -44.8% More Arrow -27.7% More Arrow 0.0%
Current ratio 667.4% More Arrow 1540.0% More Arrow 3701.8%
Return on equity (ROE) -52.6% More Arrow -29.9% More Arrow 0%
Change turnover 4,524 Less Arrow 1,677 Less Arrow 347
Change turnover % 81% Less Arrow 43% Less Arrow 10%
Chg. No. of employees 2 Equal arrow 2 More Arrow 3
Chg. No. of employees % 13% More Arrow 15% More Arrow 30%

Total value of public sale

Fiscal year 2023/08 2022/08 2021/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.